Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
607 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mater Misericordiae University Hospital
Dublin, Co Dublin, Ireland
- Mater Private Hospital
Dublin, Co Dublin, Ireland
- University College Hospital Galway
Galway, Co Galway, Ireland
- Fundacion de Investigacion de Diego
San Juan, Puerto Rico
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- Saint Jude Medical Center
Fullerton, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Eisenhower Medical Center
Rancho Mirage, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, United States
- Sutter Pacific Medical Foundation
Santa Rosa, California, United States
- Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Boulder Community Foothills Hospital
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jan 2011
- Primary completion
- 25 Jan 2019
- Completion
- 31 Mar 2027
- Last update posted
- 1 May 2026
- Registered enrollment
- 226
- Registry id
- NCT01169337
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.